Advertisement
Screener

Metagenomi Therapeutics, Inc. (MGX) Market Cap

Metagenomi Therapeutics, Inc. (MGX) Market Cap

  • 2026-09-03: Market Cap $44.2M.
  • 2026-08-06: Market Cap $46.84M.
  • 2026-06-30: Market Cap $44.95M.
  • 2026-05-05: Market Cap $53.08M.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2024-03-31 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$44.2M
2026-08-06$46.84M
2026-06-30$44.95M
2026-05-05$53.08M
2026-03-31$50.45M
2026-03-02$57.56M
2025-12-31$60.95M
2025-09-30$88.99M
2025-08-05$83.7M
2025-06-30$55.55M
2025-05-07$54.2M
2025-03-31$50.84M
2025-03-07$77.38M
2024-12-31$135.08M
2024-11-07$76.34M
2024-09-30$81.23M
2024-08-07$133.25M
2024-06-30$152.84M
2024-05-08$254.76M
2024-03-31$395.29M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Scilex Holding Co (SCLX)United States$0.042B-0.14
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
BioAtla, Inc. (BCAB)United States$0.058B-0.21